[
    [
        {
            "time": "",
            "original_text": "药明康德、药明生物、泰格…中国CXO高速增长的秘密",
            "features": {
                "keywords": [
                    "药明康德",
                    "药明生物",
                    "泰格",
                    "CXO",
                    "高速增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德、药明生物、泰格…中国CXO高速增长的秘密",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "干货！2021年中国医药制造外包(CMO)行业龙头企业对比：药明康德VS凯莱英 谁占据领先位置？",
            "features": {
                "keywords": [
                    "药明康德",
                    "凯莱英",
                    "CMO",
                    "龙头企业",
                    "对比"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "外包服务"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "干货！2021年中国医药制造外包(CMO)行业龙头企业对比：药明康德VS凯莱英 谁占据领先位置？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "融资客青睐6股，大秦铁路买入占比高达50.02%",
            "features": {
                "keywords": [
                    "融资客",
                    "大秦铁路",
                    "买入占比"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "交通运输"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "融资客青睐6股，大秦铁路买入占比高达50.02%",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]